Health & Medicine
FDA Approves Durata Drug to Treat Acute Skin Infections
The Food and Drug Administration announced Friday announced that it has approved Durata Therapeutics' drug Dalvance (dalbavancin) that treats skin infections.
Latest Research Articles
Researchers Develop Small Dialysis Machine for Newborns with Kidney Injuries
Women Happier at Work than Home, Study Finds
Microbes Break Genetic Code Quite Often, Study Finds [Video]
New Vaccine Traps Malaria In Blood Cells
Nearly 5000 People Exposed to Hepatitis A
The "Selfishness" of Soil Bacteria is Saving Us From Catastrophe
Sweetest Artificial Sweetener Yet Earns Approval
Healthy Placentas are Home to Several Good Germs: Study
Disturbed Circadian Rhythm, Junk Food Linked to Inflammation
Double Mastectomy Not Recommended for Most Breast Cancer Patients
Red Wine Fights Cavities Too?
Population Booms Result In Parasite Abundance
MOST POPULAR
-
New World Screwworm Discovered For The First Time In The US: Is An Outbreak Of 'Human-Eating' Parasite Imminent?
-
The Truth Behind the Piper Alpha Disaster - What Really Happened in the North Sea Incident That Took 167 Lives?
-
Is Yerba Mate Nature's Ozempic? Weighing In Risk Vs. Benefits
-
WATCH: 'Ed the Zebra' Airlifted Home After More than a Week on the Run in Tennessee
-
Enjoying Nature: How Outdoor Activities Can Benefit Children & Teens
